Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;95(4):1991-7.
doi: 10.1210/jc.2009-2283. Epub 2010 Feb 15.

Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women

Faryal S Mirza  1 , I Desmond Padhi, Lawrence G Raisz, Joseph A Lorenzo
Affiliations

Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women

Faryal S Mirza et al. J Clin Endocrinol Metab. 2010 Apr.

Abstract

Context: Sclerostin is a negative regulator of bone formation.

Objective: The aim of the study was to compare serum sclerostin levels in premenopausal and postmenopausal women and evaluate its relationship to estrogen, TH, bone turnover, and bone mass.

Design, setting, and participants: We conducted a cross-sectional observational study of healthy community-dwelling pre- and postmenopausal women.

Intervention(s): There were no interventions.

Main outcome measure(s): We compared serum sclerostin levels in pre- and postmenopausal women and correlated sclerostin levels with female sex hormones, calciotropic hormones, bone turnover markers, and bone mineral density.

Results: Premenopausal women were 26.8 yr old, and postmenopausal women were 56.8 yr old. Postmenopausal women had lower values for estradiol (30 +/- 23 vs. 10 +/- 4 pg/ml; P < 0.001), estrone (61 +/- 24 vs. 29 +/- 10 pg/ml; P <0.001), and free estrogen index (FEI) (6 +/- 4 vs. 3 +/- 2 pmol/nmol; P = 0.008) and significantly lower bone mineral density at all sites compared to premenopausal women, with no significant differences in levels of PTH, 25-hydroxy or 1,25-dihydroxy vitamin D levels. Postmenopausal women had significantly higher serum sclerostin levels (1.16 +/- 0.38 ng/ml vs. 0.48 +/- 0.15 ng/ml; P < 0.001). Because most of the premenopausal women were on oral contraceptives, subsequent analyses were limited to postmenopausal women. There were significant negative correlations between sclerostin and FEI and sclerostin and PTH in this group. Using multiple regression analysis, both FEI (beta = -0.629; P = 0.002) and PTH (beta = -0.554; P = 0.004) were found to be independent predictors of sclerostin levels in postmenopausal women.

Conclusions: Our findings suggest that serum sclerostin levels are regulated by both estrogens and PTH in postmenopausal women. These findings need to be explored further in larger prospective studies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Correlation of serum sclerostin levels with FEI in postmenopausal women.
Figure 2
Figure 2
Correlation of serum sclerostin levels with serum PTH levels in postmenopausal women.
See this image and copyright information in PMC

References

    1. Stepnick LS 2004 The frequency of bone disease. In: MacGowan JALGR, Noonan AS, Elderkin AL, eds. Bone health and osteoporosis: a report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General; 68–87
    1. Riggs BL, Khosla S, Melton 3rd LJ 1998 A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 13:763–773 - PubMed
    1. Day TF, Guo X, Garrett-Beal L, Yang Y 2005 Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8:739–750 - PubMed
    1. Rawadi G, Vayssière B, Dunn F, Baron R, Roman-Roman S 2003 BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 18:1842–1853 - PubMed
    1. Baron R, Rawadi G 2007 Wnt signaling and the regulation of bone mass. Curr Osteoporos Rep 5:73–80 - PubMed

Publication types